Association for Molecular Pathology v. Myriad Genetics

Docket No.	Op. Below	Argument	Opinion	Vote	Author	Term
11-725	Fed. Cir.	Not Argued	Mar 26, 2012	TBD	TBD	OT 2011

Issue: (1) Whether human genes are patentable; and (2) whether petitioners, who have been indisputably deterred by Myriad’s “active enforcement” of its patent rights, lack standing to challenge those patents absent evidence that they have been personally and directly threatened with an infringement action.

Judgment: Granted, vacated, and remanded in light of Mayo Collaborative Services v. Prometheus Laboratories, Inc. on March 26, 2012.

Briefs and Documents

Opinion below (Fed. Cir.)
Petition for certiorari
Brief in opposition
Amicus brief of American Medical Association et al.
Amicus brief of The National Women's Health Network et al.
Amicus brief of Kaiser Permanente
Amicus brief of AARP
Amicus brief of Yale Law Information Society Project
Amicus brief of Kali Murray and Erika George
Amicus brief of the Canavan Foundation et al.
Amicus brief of Cancer Counsel Australia et al.
Amicus brief of Certain Academics in Law, Medicine, Health Policy and Clinical Genetics
Amicus brief of of Knowledge Ecology International
Reply for petitioners

Breaking News

Association for Molecular Pathology v. Myriad Genetics

Briefs and Documents

Certiorari-stage documents

Jan. 6 defendant asks Supreme Court to throw out obstruction charge

Rideshare companies ask justices to reexamine California worker-protection law

Purposes and consequences: A conversation with Justice Stephen Breyer

Court rules for property owner in building fee dispute